Trademark Overview
On Monday, September 27, 2021, a trademark application was filed for TUNERO with the United States Patent and Trademark Office. The USPTO has given the TUNERO trademark a serial number of 97048097. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 26, 2023. This trademark is owned by Otsuka America, Inc.. The TUNERO trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable computer software for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment; Software as a Medical Device (SaMD), downloadable, for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment
Medical services, and providing information and advice relating thereto; mental health therapy service, and providing information and advice relating thereto; providing medical information; behavioral health services in the nature of outpatient treatment and medication monitoring, and providing information and advice relating thereto; medical counselling in the nature of counseling in the field of mental health and wellness, and providing information and advice relating thereto; rehabilitation of patients with mental diseases, and providing information and advice relating thereto; psychotherapy, and providing information and advice relating thereto; cognitive therapy services, and providing information and advice relating thereto
Providing temporary use of online non-downloadable software for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment; platform as a service (PaaS) featuring computer software platforms for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment; software as a service (SaaS) for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment